RA Pain Remains Despite Treatment

JANUARY 01, 2005

A survey of 500 adults with rheumatoid arthritis (RA) revealed that 70% of the patients still experience unbearable pain, stiffness, and fatigue daily. More than one third rank their quality of life at only 5 out of 10 at best.

The survey, a collaboration between the Arthritis Foundation and Harris Interactive Inc, showed that half of the respondents' symptoms were reduced by medication.

Yet, 49% reported that they continue to modify their daily household activities because of their arthritis. Among the survey's other findings were the following:

• More than two thirds of RA patients receiving disease-modifying antirheumatic drugs (DMARDs) or biologic response modifiers (BRMs) still experience pain (70% and 71%, respectively), stiffness (69% and 75%), and fatigue (67% and 67%) daily, despite current medication use

• The 3 main concerns among patients who have been prescribed current treatments for RA (DMARDs, BRMs) are the potential for long-term health consequences (42% and 45%), an increased risk of infection (36% and 41%), and less than adequate relief from fatigue (34% and 32%)

• All of the respondents would be interested in new RA treatments that ease pain more completely or provide longer periods of relief from pain



SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.